Jerry Cacia

Jerry Cacia serves as Chief Operating Officer at Link Cell Therapies. Link Cell Therapies operates in the research sector with approximately 23.0 employees. The company is headquartered in San Francisco, California.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,468 c suite-level executives.

Outlook Google Cloud Hosting WordPress.org Mobile Friendly Google Tag Manager Remote

biotechnology research car t cells gene editing solid tumors oncology immunotherapy antibody drug conjugates target discovery cell therapy clinical trials drug development precision medicine scientific publications cell cytotoxicity immuno-oncology therapeutic agents car t technology chimeric receptors potency enhancement cancer indications biomedical research biopharmaceuticals therapeutic robustness t cell engineering clinical development preclinical studies novel targets biological sciences adaptive immunity cancer treatment research & development medical devices anticancer drugs cell-derived therapies high-throughput optimization microrna modulation therapeutic platforms exhaustion-resistance solid cancer therapies drug delivery systems biotechnology biologics patient-centric therapies molecular biology safety & efficacy strategic partnerships therapeutic innovations academic collaborations macromolecular therapeutics cancer biology hospital & health care health care health wellness & fitness

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Jerry Cacia in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Link Cell Therapies.

Jerry Cacia's Position in the MessageCEO Database

• •Jerry Cacia is 1 of 1 verified executive contact we track at Link Cell Therapies.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •36 verified contacts work at research companies in the 23.0 employee range (same size as Link Cell Therapies).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Jerry Cacia directly?

Jerry Cacia's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating Officer at Link Cell Therapies. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Jerry Cacia work for?

Jerry Cacia is Chief Operating Officer at Link Cell Therapies, a company in the research sector with 23.0 employees. The company is based in San Francisco, California.

Can I pitch or sell to Jerry Cacia?

As Chief Operating Officer at Link Cell Therapies, Jerry Cacia is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Jerry Cacia directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Jerry Cacia in?

Jerry Cacia works in the research industry as Chief Operating Officer at Link Cell Therapies. MessageCEO provides verified contact information for executives across all major industries.

Is Jerry Cacia's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Jerry Cacia's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026